CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit
NCT ID: NCT06260345
Last Updated: 2024-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2024-01-01
2030-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital
NCT06173440
Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital
NCT05798351
Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
NCT02127450
Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant Bacteria
NCT04065750
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment).
Exclusion Criteria
* Nosocomial infection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GFRUP (Groupe Francophone de Réanimation et d'Urgences Pédiatrique)
UNKNOWN
Groupe de Pathologies Infectieuses Pédiatriques (GPIP)
OTHER
Centre National de Référence des Streptocoques
UNKNOWN
Centre National de Référence des Pneumocoques
UNKNOWN
Centre National de Référence des Méningocoques et Haemophilus influenzae
UNKNOWN
Centre National de Référence des staphylocoques
UNKNOWN
Centre National de Référence des E. Coli
UNKNOWN
Association Clinique Thérapeutique Infantile du val de Marne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Levy
Role: PRINCIPAL_INVESTIGATOR
CHU Robert Debré, Paris
Corinne Levy
Role: STUDY_DIRECTOR
Association Clinique Thérapeutique Infantile du val de Marne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Association Clinique Thérapeutique Infantile du val de Marne
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAPRICE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.